Unknown

Dataset Information

0

Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.


ABSTRACT: The development of novel, tumor-selective and boron-rich compounds as potential agents for use in boron neutron capture therapy (BNCT) represents a very important field in cancer treatment by radiation therapy. Here, we report the design and synthesis of two promising compounds that combine meta-carborane, a water-soluble monosaccharide and a linking unit, namely glycine or ethylenediamine, for facile coupling with various tumor-selective biomolecules bearing a free amino or carboxylic acid group. In this work, coupling experiments with two selected biomolecules, a coumarin derivative and folic acid, were included. The task of every component in this approach was carefully chosen: the carborane moiety supplies ten boron atoms, which is a tenfold increase in boron content compared to the l-boronophenylalanine (l-BPA) presently used in BNCT; the sugar moiety compensates for the hydrophobic character of the carborane; the linking unit, depending on the chosen biomolecule, acts as the connection between the tumor-selective component and the boron-rich moiety; and the respective tumor-selective biomolecule provides the necessary selectivity. This approach makes it possible to develop a modular and feasible strategy for the synthesis of readily obtainable boron-rich agents with optimized properties for potential applications in BNCT.

SUBMITTER: Kellert M 

PROVIDER: S-EPMC8038343 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.

Kellert Martin M   Friedrichs Jan-Simon Jeshua JJ   Ullrich Nadine Anke NA   Feinhals Alexander A   Tepper Jonas J   Lönnecke Peter P   Hey-Hawkins Evamarie E  

Molecules (Basel, Switzerland) 20210403 7


The development of novel, tumor-selective and boron-rich compounds as potential agents for use in boron neutron capture therapy (BNCT) represents a very important field in cancer treatment by radiation therapy. Here, we report the design and synthesis of two promising compounds that combine <i>meta</i>-carborane, a water-soluble monosaccharide and a linking unit, namely glycine or ethylenediamine, for facile coupling with various tumor-selective biomolecules bearing a free amino or carboxylic ac  ...[more]

Similar Datasets

| S-EPMC3086385 | biostudies-literature
| S-EPMC11521004 | biostudies-literature
| S-EPMC5924368 | biostudies-literature
| S-EPMC8041385 | biostudies-literature
| S-EPMC6274384 | biostudies-literature
| S-EPMC11092781 | biostudies-literature
| S-EPMC4671067 | biostudies-literature
| S-EPMC9064012 | biostudies-literature
| S-EPMC3517111 | biostudies-literature
| S-EPMC6747754 | biostudies-literature